Three-year follow-up of a randomized phase II trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine (the TREAT study) - Kreuter, Michael; Vansteenkiste, Johan F.; Fischer, Jürgen; Eberhardt, Wilfried E. E.; Zabeck, Heike; Kollmeier, Jens; Serke, Monika; Frickhofen, Norbert; Reck, Martin; Engel-Riedel, Walburga; Neumann, Silke; Thomeer, Michiel; et al. (Journal of thoracic oncology, 2016)